Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Cirrhosis

Free Subscription 16.02.2026 1 BMC Gastroenterol 2 Gastroenterology 2 J Gastroenterol Hepatol 1 Lancet 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. OZONO Y, Kawakami H, Hatada H, Uchiyama N, et al
   Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice.
   BMC Gastroenterol. 2026 Jan 15. doi: 10.1186/s12876-026-04610.
   PubMed         Abstract available
   
   

   
   Gastroenterology

2. LUO J
   Machine Learning in Cirrhosis: Moving from Static Admission Risk to Dynamic Decision Support.
   Gastroenterology. 2026 Feb 11:S0016-5085(26)00121.
   PubMed        
   
   
3. TAKEFUJI Y
   Enhancing Inpatient Mortality Prognostication in Cirrhosis Patients Through Machine Learning Techniques.
   Gastroenterology. 2026 Feb 11:S0016-5085(26)00120.
   PubMed        
   
   

   
   J Gastroenterol Hepatol

4. XU J, Ma H, Yang W, Tu R, et al
   ATF3 Mediates the Immunoregulatory Role of the Tim-3 Pathway in Primary Biliary Cholangitis.
   J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1111/jgh.70234.
   PubMed         Abstract available
   
   
5. DENG X, Huang N, Du K, Zhang H, et al
   The Spleen Promotes Liver Sinusoidal Endothelial Cell Angiogenesis by Stimulating the TGFbeta/Smad2/3 Pathway Through GDF15.
   J Gastroenterol Hepatol. 2026;41:774-786.
   PubMed         Abstract available
   
   

   
   Lancet

6. VALENTI L, Periti G
   Once-monthly efimosfermin for non-cirrhotic MASH.
   Lancet. 2026 Feb 5:S0140-6736(25)02431-6. doi: 10.1016/S0140-6736(25)02431.
   PubMed        
   
   

   
   PLoS One

7. DOGAY US G, Innocenti F, Koc OM, Yumuk VD, et al
   Prevalence of MASLD and fibrosis in Turkey: Results from a multicenter study of at-risk populations.
   PLoS One. 2026;21:e0341214.
   PubMed         Abstract available
   
   
8. XI J, Wang S, Chen J, Law JCS, et al
   Exploration and discovery of treatment targets for primary biliary cholangitis based on plasma and cerebrospinal fluid proteomics: A multicenter mendelian randomization study.
   PLoS One. 2026;21:e0340166.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum